Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)
India
· Delayed Price · Currency is INR 3,399.45
-20.90 (-0.61%)
Dec 24, 2024, 3:29 PM IST
Torrent Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 112,238 | 107,278 | 96,202 | 85,080 | 80,046 | 79,393 | Upgrade
|
| Revenue Growth (YoY) | 9.68% | 11.51% | 13.07% | 6.29% | 0.82% | 3.47% | Upgrade
|
| Cost of Revenue | 27,482 | 26,862 | 27,352 | 24,420 | 21,464 | 21,669 | Upgrade
|
| Gross Profit | 84,756 | 80,416 | 68,850 | 60,660 | 58,582 | 57,724 | Upgrade
|
| Selling, General & Admin | 21,076 | 20,166 | 17,052 | 15,483 | 14,597 | 14,421 | Upgrade
|
| Other Operating Expenses | 27,743 | 26,573 | 23,377 | 20,865 | 19,184 | 21,599 | Upgrade
|
| Operating Expenses | 56,803 | 54,693 | 47,449 | 42,967 | 40,354 | 42,535 | Upgrade
|
| Operating Income | 27,954 | 25,724 | 21,400 | 17,693 | 18,228 | 15,189 | Upgrade
|
| Interest Expense | -2,976 | -3,526 | -3,322 | -2,529 | -3,508 | -4,484 | Upgrade
|
| Interest & Investment Income | 114.8 | 114.8 | 147.8 | 71.5 | 50.7 | 79.6 | Upgrade
|
| Currency Exchange Gain (Loss) | -39.1 | -39.1 | -180.8 | 1,695 | 319.7 | 827.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -195.6 | 314.4 | 61.1 | 76 | 21.7 | -9.5 | Upgrade
|
| EBT Excluding Unusual Items | 24,857 | 22,587 | 18,106 | 17,007 | 15,112 | 11,602 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -4,847 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 179.9 | 179.9 | 195.1 | 101.4 | 155.8 | 292 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.2 | -0.2 | 216.2 | - | - | - | Upgrade
|
| Asset Writedown | -129.7 | -129.7 | -45.6 | -2.3 | -4.8 | -28.7 | Upgrade
|
| Other Unusual Items | 883.8 | 883.8 | - | - | - | - | Upgrade
|
| Pretax Income | 25,791 | 23,521 | 18,472 | 12,259 | 15,263 | 11,866 | Upgrade
|
| Income Tax Expense | 7,767 | 6,957 | 6,019 | 4,487 | 2,744 | 1,619 | Upgrade
|
| Earnings From Continuing Operations | 18,024 | 16,564 | 12,452 | 7,772 | 12,519 | 10,247 | Upgrade
|
| Net Income | 18,024 | 16,564 | 12,452 | 7,772 | 12,519 | 10,247 | Upgrade
|
| Net Income to Common | 18,024 | 16,564 | 12,452 | 7,772 | 12,519 | 10,247 | Upgrade
|
| Net Income Growth | 34.18% | 33.02% | 60.22% | -37.92% | 22.17% | 134.88% | Upgrade
|
| Shares Outstanding (Basic) | 338 | 338 | 338 | 338 | 338 | 338 | Upgrade
|
| Shares Outstanding (Diluted) | 338 | 338 | 338 | 338 | 338 | 338 | Upgrade
|
| Shares Change (YoY) | 0.02% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 53.25 | 48.94 | 36.79 | 22.96 | 36.99 | 30.28 | Upgrade
|
| EPS (Diluted) | 53.25 | 48.94 | 36.79 | 22.96 | 36.99 | 30.28 | Upgrade
|
| EPS Growth | 34.16% | 33.02% | 60.22% | -37.92% | 22.17% | 134.88% | Upgrade
|
| Free Cash Flow | 29,293 | 28,333 | 17,942 | 16,004 | 16,702 | 9,861 | Upgrade
|
| Free Cash Flow Per Share | 86.55 | 83.72 | 53.01 | 47.29 | 49.35 | 29.14 | Upgrade
|
| Dividend Per Share | - | 28.000 | 22.000 | 16.500 | 17.500 | 8.500 | Upgrade
|
| Dividend Growth | - | 27.27% | 33.33% | -5.71% | 105.88% | 0% | Upgrade
|
| Gross Margin | 75.51% | 74.96% | 71.57% | 71.30% | 73.19% | 72.71% | Upgrade
|
| Operating Margin | 24.91% | 23.98% | 22.25% | 20.80% | 22.77% | 19.13% | Upgrade
|
| Profit Margin | 16.06% | 15.44% | 12.94% | 9.13% | 15.64% | 12.91% | Upgrade
|
| Free Cash Flow Margin | 26.10% | 26.41% | 18.65% | 18.81% | 20.87% | 12.42% | Upgrade
|
| EBITDA | 35,509 | 33,249 | 28,026 | 23,823 | 24,291 | 21,180 | Upgrade
|
| EBITDA Margin | 31.64% | 30.99% | 29.13% | 28.00% | 30.35% | 26.68% | Upgrade
|
| D&A For EBITDA | 7,556 | 7,526 | 6,626 | 6,130 | 6,063 | 5,991 | Upgrade
|
| EBIT | 27,954 | 25,724 | 21,400 | 17,693 | 18,228 | 15,189 | Upgrade
|
| EBIT Margin | 24.91% | 23.98% | 22.25% | 20.80% | 22.77% | 19.13% | Upgrade
|
| Effective Tax Rate | 30.12% | 29.58% | 32.59% | 36.60% | 17.98% | 13.64% | Upgrade
|
| Revenue as Reported | 112,308 | 107,858 | 96,653 | 87,046 | 80,615 | 80,606 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.